Cite

HARVARD Citation

    Bartlett, J. et al. (2019). Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem. Annals of pharmacotherapy. 53 (1), pp. 21-27. [Online]. 
  
Back to record